78 related articles for article (PubMed ID: 8731040)
1. Tumor necrosis factor alpha (rhTNF) fails to stimulate angiogenesis in the rabbit cornea.
Phillips GD; Stone AM; Schultz JC; Jones BD; Lisowski MJ; Goodkin ML; Knighton DR
Anat Rec; 1996 May; 245(1):53-6. PubMed ID: 8731040
[TBL] [Abstract][Full Text] [Related]
2. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor.
Knighton DR; Phillips GD; Fiegel VD
J Trauma; 1990 Dec; 30(12 Suppl):S134-44. PubMed ID: 1701493
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in P- and E-selectin-deficient mice.
Hartwell DW; Butterfield CE; Frenette PS; Kenyon BM; Hynes RO; Folkman J; Wagner DD
Microcirculation; 1998; 5(2-3):173-8. PubMed ID: 9789257
[TBL] [Abstract][Full Text] [Related]
4. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor.
Zimmerman RJ; Chan A; Leadon SA
Cancer Res; 1989 Apr; 49(7):1644-8. PubMed ID: 2924312
[TBL] [Abstract][Full Text] [Related]
5. Effect of tumor necrosis factor antibody given to horses during early experimentally induced endotoxemia.
Barton MH; Bruce EH; Moore JN; Norton N; Anders B; Morris DD
Am J Vet Res; 1998 Jun; 59(6):792-7. PubMed ID: 9622754
[TBL] [Abstract][Full Text] [Related]
6. The mouse cornea micropocket angiogenesis assay.
Rogers MS; Birsner AE; D'Amato RJ
Nat Protoc; 2007; 2(10):2545-50. PubMed ID: 17947997
[TBL] [Abstract][Full Text] [Related]
7. [Inducement effect of recombinant human TNF-alpha on apoptosis of breast cancer cell line ZR75-1 and Its mechanism].
Li YC; Kong LH; Li KS
Ai Zheng; 2006 May; 25(5):560-5. PubMed ID: 16687074
[TBL] [Abstract][Full Text] [Related]
8. IL-4 and TNF-alpha-mediated proliferation of the human megakaryocytic line M-O7E is regulated by induced autocrine production of GM-CSF.
Wadhwa M; Dilger P; Meager A; Walker B; Gaines-Das R; Thorpe R
Cytokine; 1996 Dec; 8(12):900-9. PubMed ID: 9050748
[TBL] [Abstract][Full Text] [Related]
9. Evidence of human thrombomodulin domain as a novel angiogenic factor.
Shi CS; Shi GY; Chang YS; Han HS; Kuo CH; Liu C; Huang HC; Chang YJ; Chen PS; Wu HL
Circulation; 2005 Apr; 111(13):1627-36. PubMed ID: 15795324
[TBL] [Abstract][Full Text] [Related]
10. Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice.
Postma NS; Crommelin DJ; Eling WM; Zuidema J
J Pharmacol Exp Ther; 1999 Jan; 288(1):114-20. PubMed ID: 9862761
[TBL] [Abstract][Full Text] [Related]
11. The loss of recombinant human granulocyte colony-stimulating factor and recombinant human TNF-alpha priming effects on the superoxide-generating response in exudated neutrophils is associated with a decrease in their receptor affinities.
Niwa M; Yousif AE; Kohno K; Kanamori Y; Matsuno M; Abe A; Uematsu T
J Immunol; 1996 Nov; 157(9):4147-53. PubMed ID: 8892651
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution of recombinant human tumor necrosis factor alpha derivative in mice.
Chai BX; Tang ZM; Liu XW; Tu M
Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):371-4. PubMed ID: 10452128
[TBL] [Abstract][Full Text] [Related]
13. Growth/differentiation factor-5 induces angiogenesis in vivo.
Yamashita H; Shimizu A; Kato M; Nishitoh H; Ichijo H; Hanyu A; Morita I; Kimura M; Makishima F; Miyazono K
Exp Cell Res; 1997 Aug; 235(1):218-26. PubMed ID: 9281371
[TBL] [Abstract][Full Text] [Related]
14. A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo.
Yan Z; Zhao N; Wang Z; Li B; Bao C; Shi J; Han W; Zhang Y
Cytotherapy; 2006; 8(4):415-23. PubMed ID: 16923618
[TBL] [Abstract][Full Text] [Related]
15. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process.
Presta M; Rusnati M; Belleri M; Morbidelli L; Ziche M; Ribatti D
Cancer Res; 1999 May; 59(10):2417-24. PubMed ID: 10344752
[TBL] [Abstract][Full Text] [Related]
16. Long-term toxicity of modified recombinant human tumor necrosis factor in Macaca mulatta.
Gu CH; Yuan BJ; Lu GC; Dai ZR; Liu JP; Zhang SY; Zhang P; Jiang CL
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):85-8. PubMed ID: 10375768
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of several chemicals against lethality of recombinant human tumor necrosis factor.
Satomi N; Sakurai A; Haranaka R; Haranaka K
J Biol Response Mod; 1988 Feb; 7(1):54-64. PubMed ID: 3373234
[TBL] [Abstract][Full Text] [Related]
18. In vivo angiogenic activity of interleukins.
BenEzra D; Hemo I; Maftzir G
Arch Ophthalmol; 1990 Apr; 108(4):573-6. PubMed ID: 1690981
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1-alpha and de novo mammalian angiogenesis.
Norrby K
Microvasc Res; 1997 Jul; 54(1):58-64. PubMed ID: 9245645
[TBL] [Abstract][Full Text] [Related]
20. New TNF-alpha analogues: a powerful but less toxic biological tool against tumours.
Novaković S; Menart V; Gaberc-Porekar V; Stalc A; Sersa G; Cemazar M; Jezersek B
Cytokine; 1997 Aug; 9(8):597-604. PubMed ID: 9245488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
